New eye drop shows promise for glaucoma without high pressure
NCT ID NCT06030193
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new eye drop called QLS-111 in 37 people with normal tension glaucoma, a type of glaucoma where eye pressure is not high but vision still gets damaged. The goal was to see if QLS-111 is safe and can lower eye pressure better than a standard drop called timolol. Participants used the drops for a short time while doctors checked for side effects and measured eye pressure changes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLAUCOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Seoul National University Hospital
Seoul, 3080, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A sharper look at the retina: new imaging technology may spot eye disease earlier
- Eye surgery showdown: which drainage device placement saves more vision cells?
- Eye blood flow camera could spot glaucoma before vision fades
- Could a glaucoma eye drop also heal the cornea?
- Could a smartphone camera spot blinding eye diseases?
- Could stem cells restore sight in damaged eyes?